Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             221 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A critical role in for properdin in antibody-dependent bactericidal activity against Neisseria gonorrhoeae Ram, S.
 2011
 48 14 p. 1701-
1 p.
 artikel
2 Action of Micrurus snake venoms on the human complement system Tambourgi, D.V.
 2011
 48 14 p. 1730-
1 p.
 artikel
3 Activation of complement and innate immunity during extracorporeal perfusion of amputated porcine extremities Gajanayake, T.
 2011
 48 14 p. 1694-
1 p.
 artikel
4 A differential C4bp binding ability of Borrelia and Francisella strains Madar, M.M.
 2011
 48 14 p. 1703-
1 p.
 artikel
5 Alkaline protease of Pseudomonas aeruginosa evades innate immunity by blocking activation of complement C2 and Toll-like receptor 5 Bardoel, B.W.
 2011
 48 14 p. 1670-1671
2 p.
 artikel
6 Alpha-enolase of Streptococcus pneumoniae binds the human complement inhibitor C4-binding protein and mediates pneumococcal complement evasion Agarwal, V.
 2011
 48 14 p. 1698-
1 p.
 artikel
7 Altered CR2 function primes for IL-10 production by B cells Hayes, C.M.
 2011
 48 14 p. 1717-
1 p.
 artikel
8 AMD-associated complement factor H variant Y402H protects from streptococcal infections—Evidence from bacterial in vitro survival and human genetic association studies Haapasalo-Tuomainen, K.H.T.
 2011
 48 14 p. 1699-
1 p.
 artikel
9 A mutant version of factor H that could block the activity of wild-type factor H – Implications for atypical haemolytic uraemic syndrome McIntosh, N.
 2011
 48 14 p. 1710-
1 p.
 artikel
10 Analysis of binding sites on complement factor I required for its activity using artificial N-linked glycosylation Sánchez Gallego, J.I.
 2011
 48 14 p. 1705-
1 p.
 artikel
11 A new concept for autoregulation of complement activation on cell surfaces Teramura, Yuji
 2011
 48 14 p. 1711-
1 p.
 artikel
12 A new functional test for human fH Brouwer, M.C.
 2011
 48 14 p. 1708-
1 p.
 artikel
13 A new model of atypical haemolytic uraemic syndrome Vernon, K.A.
 2011
 48 14 p. 1678-
1 p.
 artikel
14 An immunoassay for the quantitation of complement fragment C4a in vitro DeForest, N.
 2011
 48 14 p. 1686-
1 p.
 artikel
15 A novel mechanism of immune evasion in Leptospira: The expression of proteases that cleave complement proteins Fraga, T.R.
 2011
 48 14 p. 1700-
1 p.
 artikel
16 A novel mouse model of systemic lupus erythematosus (SLE) and atherosclerosis: Distinct roles of complement in the kidney and atherosclerotic plaques Botto,
 2011
 48 14 p. 1681-
1 p.
 artikel
17 A novel role of complement in retinal degeneration Liu, J.
 2011
 48 14 p. 1680-
1 p.
 artikel
18 Antagonists of complement C6 affect neurodegeneration Fluiter, K.
 2011
 48 14 p. 1714-
1 p.
 artikel
19 Antibodies and complement are deposited in viable myocardium in a porcine model of acute coronary syndrome Kamat, J.
 2011
 48 14 p. 1671-
1 p.
 artikel
20 Anti-complement activity of scabies mite serine proteases Reynolds, S.L.
 2011
 48 14 p. 1697-1698
2 p.
 artikel
21 Anti-C1q antibodies and C1q in SLE: Comparison between methods and relation to nephritis and disease activity Skattum, L.S.
 2011
 48 14 p. 1724-
1 p.
 artikel
22 Anti-factor H auto-antibodies in C3 glomerulopathy Dragon-Durey, M.A.
 2011
 48 14 p. 1724-
1 p.
 artikel
23 Anti-factor H autoantibodies in systemic lupus erythematosus Nilsson, S.
 2011
 48 14 p. 1725-
1 p.
 artikel
24 Association of Chagas disease with functional MASP2 polymorphisms identified with multiplex sequence-specific PCR Boldt, A.B.W.
 2011
 48 14 p. 1667-1668
2 p.
 artikel
25 Association of Ficolin-3 with severity and outcome of chronic heart failure Prohaszka, Z.
 2011
 48 14 p. 1679-1680
2 p.
 artikel
26 Association study of complement C2, C3 and factor B, and age-related macular degeneration in a Greek population Zarkadis, I.K.
 2011
 48 14 p. 1723-
1 p.
 artikel
27 Beta 2 glycoprotein 1 (beta 2GPI), the major target in anti phospholipid syndrome (APS), regulates complement activation on the level of C3/C3b Skerka, C.
 2011
 48 14 p. 1675-
1 p.
 artikel
28 Binding of C4b binding protein to Yersinia pseudotuberculosis Ail Ho, D.
 2011
 48 14 p. 1696-1697
2 p.
 artikel
29 Binding of Ficolin-1 to the long pentraxin PTX3: Interacting domain and function on apoptotic cells Ma Ma, Y.J.
 2011
 48 14 p. 1707-
1 p.
 artikel
30 Borrelia valaisiana overcome complement-mediated killing independendly from the recruitment of complement regulators Kraiczy, P.
 2011
 48 14 p. 1696-
1 p.
 artikel
31 Both nucleosomes and C1q bind to glomerular endothelial cells in vitro, serve as targets for autoantibodies and determine complement activation Flynn, J.O.
 2011
 48 14 p. 1727-1728
2 p.
 artikel
32 C5a activates NKT and NK cells in sepsis Köhl, J.
 2011
 48 14 p. 1672-
1 p.
 artikel
33 C3a drives Th17 lineage decisions in humans via induction of IL-1beta production in monocytes Asgari, E.
 2011
 48 14 p. 1671-
1 p.
 artikel
34 C5a in microdialysis fluid discriminates ischemia from rejection in liver grafts Thorgersen, E.B.
 2011
 48 14 p. 1715-
1 p.
 artikel
35 C5a modulates cytokine production critical for intestinal inflammation in inflammatory bowel disease Reinicke, A.T.
 2011
 48 14 p. 1670-
1 p.
 artikel
36 C3 and CD46 deficiencies: Similar B cell phenotype and defect in Th1/Th2/Tr1 polarization Ghannam, A.
 2011
 48 14 p. 1721-1722
2 p.
 artikel
37 C5aR but not C3aR signaling in mDCs differentially regulates maladaptive immunity and inflammation in house dust mite-mediated experimental allergic asthma Engelke,
 2011
 48 14 p. 1691-1692
2 p.
 artikel
38 C5a receptor is cleaved by metalloproteases induced by loxosceles spider venom van den Berg, C.W.
 2011
 48 14 p. 1694-
1 p.
 artikel
39 C5a receptor is critical for Flt3L-driven generation of functional plasmacytoid dendritic cells in vitro Laumonnier,
 2011
 48 14 p. 1691-
1 p.
 artikel
40 C5aR signalling in mDCs drives the development of experimental allergic asthma Schmudde, I.
 2011
 48 14 p. 1689-
1 p.
 artikel
41 CD14 blockade down-regulates kidney C3 gene expression in Escherichia coli-induced sepsis in vivo in pigs Pischke, S.E.
 2011
 48 14 p. 1693-
1 p.
 artikel
42 Challenging pattern recognition cross-talk: A gene profiling perspective of human Gram-negative bacteriaemia Lau, C.L.
 2011
 48 14 p. 1691-
1 p.
 artikel
43 Characterization of the glomerular endothelial binding sites for full-length complement factor H (FH) and for FH19–20 and FH5–7 domains Rops, L.W.M.M.
 2011
 48 14 p. 1688-
1 p.
 artikel
44 Chemical chaperones curcumin and phenyl butyric acid improve secretion of mutant Factor H R127H by the patient fibroblasts Albuquerque, Ms José Antonio T.
 2011
 48 14 p. 1714-1715
2 p.
 artikel
45 C1 inhibitor efficiently inhibits Escherichia coli and LPS-induced tissue factor expression on monocytes and mRNA upregulation in human whole blood Fure, H.F.
 2011
 48 14 p. 1669-
1 p.
 artikel
46 C3 is required for host protection to influenza Carroll, M.
 2011
 48 14 p. 1702-
1 p.
 artikel
47 Cloning and characterization of genes coding for C3 and factor B complement system components from Loxosceles laeta spider venom glands Myamoto, D.T.
 2011
 48 14 p. 1682-
1 p.
 artikel
48 COMP-C3b as a molecular marker for inflammatory joint diseases Happonen, E.
 2011
 48 14 p. 1720-
1 p.
 artikel
49 Complement activation by (auto-) antibodies Daha, Nina A.
 2011
 48 14 p. 1656-1665
10 p.
 artikel
50 Complement activation defects in pediatric oncology patients Keizer, S.M.P.D.
 2011
 48 14 p. 1686-
1 p.
 artikel
51 Complement activation in Alzheimer's disease Rutjes-van den Hurk, W.H.
 2011
 48 14 p. 1695-
1 p.
 artikel
52 Complement activation in animal and human pregnancies as a model for immunological recognition Girardi, Guillermina
 2011
 48 14 p. 1621-1630
10 p.
 artikel
53 Complement activation in thrombotic thrombocytopenic purpura Prohaszka, Z.
 2011
 48 14 p. 1719-
1 p.
 artikel
54 Complement and neuronal damage in deep grey matter multiple sclerosis lesions Huitinga, I.
 2011
 48 14 p. 1727-
1 p.
 artikel
55 Complement C3 impairs fibrinolysis: Implications for cardiovascular disease Richardson, R.
 2011
 48 14 p. 1728-
1 p.
 artikel
56 Complement C4 in SLE Carroll, M.
 2011
 48 14 p. 1729-
1 p.
 artikel
57 Complement component 5 deficiency (C5D) in South Africa Orren, A.
 2011
 48 14 p. 1683-
1 p.
 artikel
58 Complement deficiency states and associated infections Skattum, Lillemor
 2011
 48 14 p. 1643-1655
13 p.
 artikel
59 Complement depletion with humanized Cobra Venom Factor (CVF) improves the severity of Experimental Autoimmune Myasthenia Gravis (EAMG) Huda, R.
 2011
 48 14 p. 1712-
1 p.
 artikel
60 Complement evasion by Neisseria meningitidis Jongerius, I.
 2011
 48 14 p. 1701-
1 p.
 artikel
61 Complement-factor C5a modulates vein graft remodeling and accelerated atherosclerosis via interference in Mast cell activation Wezel, A.
 2011
 48 14 p. 1693-
1 p.
 artikel
62 Complement factor H (CFH) haploinsufficiency causes spontaneous late onset glomerulonephritis Noris, M.
 2011
 48 14 p. 1723-
1 p.
 artikel
63 Complement Factor H-related protein 5 deficiency is a risk factor for chronic renal disease following acute post-streptococcal glomerulonephritis Vernon, K.A.
 2011
 48 14 p. 1728-
1 p.
 artikel
64 Complement Factor I deficiency in four Spanish families Alba, M.A.
 2011
 48 14 p. 1684-
1 p.
 artikel
65 Complement factor I in health and disease Nilsson, Sara C.
 2011
 48 14 p. 1611-1620
10 p.
 artikel
66 Complement fragments and the pathogenesis of polymyositis Basta, M.
 2011
 48 14 p. 1731-
1 p.
 artikel
67 Complement in diabetic nephropathy Kotnik, V.
 2011
 48 14 p. 1719-1720
2 p.
 artikel
68 Complement inhibition prevents granulocyte activation caused by candidate biomaterials for an implantable microfabricated device Sokolov, A.
 2011
 48 14 p. 1689-
1 p.
 artikel
69 Complement in the brain Veerhuis, Robert
 2011
 48 14 p. 1592-1603
12 p.
 artikel
70 Complement MBL-associated serine protease-1 (MASP-1) interacts with plasma clot formation - a novel link between inflammation and thrombosis? Schroeder, V.S.
 2011
 48 14 p. 1675-
1 p.
 artikel
71 Complement-mediated acute induction of endothelial-to-mesenchymal transition (EndMT) in a swine model of renal ischemia/reperfusion>(I/R) injury Castellano, G.C.
 2011
 48 14 p. 1692-
1 p.
 artikel
72 Complement mediated hypersensitivity to nanomedicines Szebeni, J.
 2011
 48 14 p. 1715-
1 p.
 artikel
73 Complement receptor 1 (CR1, CD35) binds CpG-DNA Lepse, N.
 2011
 48 14 p. 1687-
1 p.
 artikel
74 Complement regulator factor H (fH) levels in CSF of mild cognitive impairment (MCI) cases depend on the Y402H polymorphism Hakobyan, S.
 2011
 48 14 p. 1733-
1 p.
 artikel
75 Complement system modulation by components from Rhinella schneideri poison Anjolette, F.A.P.
 2011
 48 14 p. 1694-1695
2 p.
 artikel
76 C1q induces in vivo angiogenesis and promotes wound healing Bossi, F.
 2011
 48 14 p. 1676-1677
2 p.
 artikel
77 C1q is associated with a reduced inflammatory response of decidual endothelial cells Masat, E.
 2011
 48 14 p. 1692-
1 p.
 artikel
78 C1q regulation of dendritic cell development: Distinct cytokine production and T cell stimulation Lu, J.
 2011
 48 14 p. 1725-
1 p.
 artikel
79 Cryo electron tomographic visualization of antigen bound antibodies and fitting of atomic models Diebolder, C.A.
 2011
 48 14 p. 1709-
1 p.
 artikel
80 Crystal structure of MASP-2 in complex with a highly selective phage display evolved inhibitor Harmat, V.
 2011
 48 14 p. 1674-
1 p.
 artikel
81 Deciphering Complement Receptor 1 (CR1) interaction with defence collagens Jacquet, M.C.
 2011
 48 14 p. 1705-
1 p.
 artikel
82 Decreased ability to degrade neutrophil extracellular traps leads to complement activation resulting in a more severe course of systemic lupus erythematosus Leffler, J.
 2011
 48 14 p. 1680-1681
2 p.
 artikel
83 Decreased complement factor H is associated with cardiovascular risk in South Asian relatives of patients with type 2 diabetes mellitus Richardson, R.
 2011
 48 14 p. 1728-1729
2 p.
 artikel
84 Dense deposit disease Smith, Richard J.H.
 2011
 48 14 p. 1604-1610
7 p.
 artikel
85 Dense deposit disease—A 2011 update Smith, R.J.H.
 2011
 48 14 p. 1679-
1 p.
 artikel
86 Despite relative C9-deficiency, neonatal serum is bactericidal for Ureaplasma serovar 3, but addition of C6–C9 and specific IgG fails to induce killing of serovars 6 and 14 Abdulla, S.
 2011
 48 14 p. 1702-1703
2 p.
 artikel
87 Diagnostic significance of hypocomplementemia in Asian population with acute nephritic syndrome and rapidly progressive glomerulonephritis Gojaseni, P.
 2011
 48 14 p. 1726-
1 p.
 artikel
88 Differences of complement activation profile between type I and type II of hereditary angioedema due to C1-inhibitor deficiency Csuka,
 2011
 48 14 p. 1720-
1 p.
 artikel
89 Differential binding of CFHR5 and factor H to C3 metabolites suggests that these two proteins regulate complement activation at different stages de Jorge, E. Goicoechea
 2011
 48 14 p. 1675-
1 p.
 artikel
90 Differential expression of gC1qR in normal and pathologic human tissue Peerschke, I.B.
 2011
 48 14 p. 1718-
1 p.
 artikel
91 Diminished neutrophil chemotaxis to C5a in vitamin D binding protein deficient mice Kew, R.
 2011
 48 14 p. 1670-
1 p.
 artikel
92 Disease-modifying genes in hereditary angioedema López-Lera, A.
 2011
 48 14 p. 1682-1683
2 p.
 artikel
93 Dissecting the Factor H binding site of Neisseria meningitidis Factor H binding protein Johnson, S.J.
 2011
 48 14 p. 1727-
1 p.
 artikel
94 Editorial Board 2011
 48 14 p. CO2-
1 p.
 artikel
95 Electron microscopy of iC3b Llorca, O.
 2011
 48 14 p. 1704-
1 p.
 artikel
96 Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice Tong, H.T.
 2011
 48 14 p. 1668-
1 p.
 artikel
97 Evasion of the alternative complement pathway by Photorhabdus spp. Beeton, M.L.
 2011
 48 14 p. 1703-
1 p.
 artikel
98 Evolution of the FCN2 promoter polymorphism Boldt, A.B.W.
 2011
 48 14 p. 1684-
1 p.
 artikel
99 Exome capture and array comparative genomic hybridization of a monozygotic twin pair discordant for dense deposit disease Cruz Corchado, J.C.C.
 2011
 48 14 p. 1685-
1 p.
 artikel
100 Expression and function of CR1 and CR2 on B cells of rheumatoid arthritis patients Kremlitzka,
 2011
 48 14 p. 1715-1716
2 p.
 artikel
101 Extended role for antibodies anti-Factor H in alternative pathway dysregulation in a context of atypical hemolytic uremic syndrome (aHUS) Blanc, C.
 2011
 48 14 p. 1725-
1 p.
 artikel
102 Ex vivo xenoperfusion of CD46 & HLA-E double transgenic pig limbs: Effect of transgenic expression of human CD46 Bongoni, B.
 2011
 48 14 p. 1671-1672
2 p.
 artikel
103 Factor H and MCP haplotypes don’t confer susceptibility for C3 glomerulopathy Lequintrec, M.
 2011
 48 14 p. 1724-
1 p.
 artikel
104 Factor H-related protein 4 can serve as a platform for the assembly of an active C3 convertase via its interaction with C3b Hebecker, M.
 2011
 48 14 p. 1706-
1 p.
 artikel
105 Ficolin-2 and FCN2 in patients with systemic inflammation Munthe-Fog, L.
 2011
 48 14 p. 1693-
1 p.
 artikel
106 Ficolin-1 expression reflects FCN1 genotypic variation Munthe-Fog, L.M.F.
 2011
 48 14 p. 1685-
1 p.
 artikel
107 Ficolins and MASPs in hereditary angioedema due to C1 inhibitor deficiency Varga,
 2011
 48 14 p. 1721-
1 p.
 artikel
108 Ficolin-3 serum levels are strongly associated with outcome of ischemic stroke Füst, G.
 2011
 48 14 p. 1718-1719
2 p.
 artikel
109 Fresh frosen plasma in therapy of hereditary angioedema Savic, O.
 2011
 48 14 p. 1714-
1 p.
 artikel
110 Functional serum antibody profiles in autoimmune disease diagnostics Papp, K.
 2011
 48 14 p. 1732-
1 p.
 artikel
111 Galactosylated IgG1 links FcRIIB and dectin-1 to suppress C5aR-mediated inflammation Karsten, C.M.K.
 2011
 48 14 p. 1669-
1 p.
 artikel
112 Genetic variants in CFH and CD46 are the major susceptibility factors for aHUS—An association study of multiple complement genes Ermini, L.
 2011
 48 14 p. 1667-
1 p.
 artikel
113 Genetic variants of C1q are a risk for rheumatoid arthritis Daha, N.A.
 2011
 48 14 p. 1667-
1 p.
 artikel
114 Glomerular endothelial microvascular heterogeneity and response to cytokines predispose to the development of atypical HUS Richards, A.
 2011
 48 14 p. 1732-
1 p.
 artikel
115 Heme interacts with C1Q and inhibits the classical complement pathway Roumenina, L.T.
 2011
 48 14 p. 1706-
1 p.
 artikel
116 High prevalence of hybrid genes involving CFH and CFHR1 in atypical Hemolytic Uremic Syndrome Fremeaux-Bacchi, V.
 2011
 48 14 p. 1666-
1 p.
 artikel
117 Human complement factor H-related protein 2 (CFHR2) represents a novel complement regulator, which is reduced in a patient with MPGN I Eberhardt, H.E.
 2011
 48 14 p. 1674-
1 p.
 artikel
118 Human complement regulators interact with leptospiral immunoglobulin-like proteins contributing to immune evasion Castiblanco-Valencia, M.M.
 2011
 48 14 p. 1700-1701
2 p.
 artikel
119 Human complement system activation by a serine protease found in the Premolis semirufa caterpillar venom Villas Boas, I.M.
 2011
 48 14 p. 1704-
1 p.
 artikel
120 Hyperglycemic conditions inhibit C3-mediated host defenses against bacterial pathogens and change the tertiary structure of C3 Cunnion, K.M.
 2011
 48 14 p. 1695-1696
2 p.
 artikel
121 Identification of a CYP2E1/BID/C1q-dependent axis mediating inflammation in adipose tissue after chronic ethanol feeding to mice Nagy, L.E.
 2011
 48 14 p. 1726-
1 p.
 artikel
122 Identification of a novel hybrid CFHR2/CFHR5 gene in MPGN II/DDD patients Chen, Q.
 2011
 48 14 p. 1722-1723
2 p.
 artikel
123 Identification of epitopes on the collagen-like region of C1q recognized by serum antibodies from patients with lupus erythematosus Vanhecke, D.
 2011
 48 14 p. 1720-1721
2 p.
 artikel
124 Identification of Staphylococcus aureus surface protein SdrE as a complement factor H-binding molecule Cunnion, K.M.
 2011
 48 14 p. 1695-
1 p.
 artikel
125 Impaired binding of factor H to pentraxin 3 due to factor H mutations and autoantibodies associated with atypical hemolytic uremic syndrome Braunschweig, A.
 2011
 48 14 p. 1722-
1 p.
 artikel
126 Increased renal C5a receptor expression and systemic complement activation in brain dead donors van Werkhoven, M.B.
 2011
 48 14 p. 1729-
1 p.
 artikel
127 Independent roles for complement C3a and C5a receptors and the membrane attack complex in the pathogenesis of collagen antibody-induced arthritis in mice: Potential therapeutic implications Banda, N.K.
 2011
 48 14 p. 1670-
1 p.
 artikel
128 Inhibiting the C5–C5a receptor axis Woodruff, Trent M.
 2011
 48 14 p. 1631-1642
12 p.
 artikel
129 In patients with atypical hemolytic uremic syndrome C5 activation causes loss of endothelial thromboresistance Galbusera, M.
 2011
 48 14 p. 1680-
1 p.
 artikel
130 Interim analysis of phase II efficacy and safety data for eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) receiving chronic plasma exchange/infusion Goodship, T.H.J.
 2011
 48 14 p. 1712-
1 p.
 artikel
131 Investigating host specificity of Neisseria meningitidis Everett, J.
 2011
 48 14 p. 1673-
1 p.
 artikel
132 Investigations on the cell surface calreticulin-C1q interactions and their involvement in the uptake of apoptotic cells Verneret, M.
 2011
 48 14 p. 1706-
1 p.
 artikel
133 Investigations on the pattern recognition molecule M-ficolin: Specificity towards bacteria Thiel, S.
 2011
 48 14 p. 1702-
1 p.
 artikel
134 Islet amyloid polypeptide triggers limited complement activation and binds complement inhibitor C4b-binding protein, which enhances fibril formation Sjölander, J.
 2011
 48 14 p. 1719-
1 p.
 artikel
135 Isolation and characterization of a complement activating metalloproteinase from Bothrops pirajai snake venom Queiroz, Pidde
 2011
 48 14 p. 1708-
1 p.
 artikel
136 Karilysin, metalloproteinase present in majority of Tannerella forsythia isolates inhibits all pathways of the complement system Jusko, J.M.
 2011
 48 14 p. 1696-
1 p.
 artikel
137 Key role of the number of erythrocyte CR1 on the initial erythrocyte binding, phagocytosis and oxidative burst by Escherichia coli in human whole blood Brekke, O.L.B.
 2011
 48 14 p. 1672-1673
2 p.
 artikel
138 Mannose binding lectin as a target for cerebral ischemic injury Orsini, F.
 2011
 48 14 p. 1677-
1 p.
 artikel
139 Mannose-binding lectin induces tubular epithelial cell death following renal ischemia reperfusion injury independent of complement activation van der Pol, P.
 2011
 48 14 p. 1679-
1 p.
 artikel
140 MAp19, the alternative splice product of the MASP2 gene Degn, S.E.
 2011
 48 14 p. 1709-
1 p.
 artikel
141 MBL2 genotypes and kidney graft survival Bay, Jakob T.
 2011
 48 14 p. 1683-1684
2 p.
 artikel
142 Mechanism of the activation of the lectin pathway Gál, P.
 2011
 48 14 p. 1685-1686
2 p.
 artikel
143 Membrane Attack Complex deposition on Gram-positive bacteria Berends, E.T.M.
 2011
 48 14 p. 1703-
1 p.
 artikel
144 M-ficolin interacts with the long pentraxin PTX3: A novel case of cross-talk between soluble pattern-recognition molecules Gout, E.
 2011
 48 14 p. 1704-
1 p.
 artikel
145 MicroRNA profiles of CD46-stimulated T cells King, B.C.R.
 2011
 48 14 p. 1691-
1 p.
 artikel
146 Misinterpretation of complement activation in urine van der Pol, P.
 2011
 48 14 p. 1727-
1 p.
 artikel
147 Modulation of classical complement pathway associated with increase of the procoagulant factors by hormonal contraceptive using Bertozi, R.
 2011
 48 14 p. 1690-
1 p.
 artikel
148 Molecular basis of hereditary C1q deficiency-revisited: Identification of several novel disease causing mutations Schejbel, L.
 2011
 48 14 p. 1723-
1 p.
 artikel
149 Molecular characterization and clinical history of a homozygous functional C1q abnormality Roumenina, L.T.
 2011
 48 14 p. 1722-
1 p.
 artikel
150 Monoclonal anti-factor H antibodies in dense deposit disease López-Trascasa, M.
 2011
 48 14 p. 1726-
1 p.
 artikel
151 Mutations in the CFHR5 gene and in genes encoding components of the membrane attack complex in patients with atypical hemolytic uremic syndrome Westra, D.
 2011
 48 14 p. 1682-
1 p.
 artikel
152 New treatment of multiple mieloma and anaplastic T cell lymphoma using C-fixing anti-CD162 antibodies Mezzaroba, N.
 2011
 48 14 p. 1713-
1 p.
 artikel
153 No involvement of antibodies and complement in the onset of tourniquet-induced ischemia/reperfusion injury in hand surgery Kamat, J.
 2011
 48 14 p. 1694-
1 p.
 artikel
154 Non-physiological osmolarity and pH in peritoneal dialysis fluid impair complement regulation in rat peritoneal mesothelial cells Mizuno, M.
 2011
 48 14 p. 1690-
1 p.
 artikel
155 No prominent role for complement complex C5b-9 in early ischemia-reperfusion injury in clinical kidney transplantation de Vries, D.K.
 2011
 48 14 p. 1730-
1 p.
 artikel
156 Normal and acute phase variations of MASP-1, an enzyme associated with humoral pattern recognition molecules Thiel, S.
 2011
 48 14 p. 1710-
1 p.
 artikel
157 Novel DNA alterations in FCN1 and FCN2 genes in atypical HUS patients Volokhina, E.B.
 2011
 48 14 p. 1684-
1 p.
 artikel
158 Novel scabies mite serpins inhibit the three pathways of the human complement system Mika, A.
 2011
 48 14 p. 1698-
1 p.
 artikel
159 Optimising measurement of terminal complement components in adult and newborn serum by ELISA by refining capture antibodies and purified standards Abdulla, S.
 2011
 48 14 p. 1687-
1 p.
 artikel
160 Ornithodoros moubata complement inhibitor (OmCI) is an equally effective C5 inhibitor in pig and human, and combined with CD14 inhibition, efficiently attenuate Escherichia coli-induced sepsis in pigs Barratt-Due, A.
 2011
 48 14 p. 1699-
1 p.
 artikel
161 ‘Pauci-immune’ dense deposit disease Nester, C.M.
 2011
 48 14 p. 1732-
1 p.
 artikel
162 Perioperative increase in plasma concentration of SC5b-9 predicts damage in transplanted liver Koskinen, A.R.
 2011
 48 14 p. 1677-1678
2 p.
 artikel
163 Platelet C1q, C4 and C3 deposition in SLE and the association to vascular disease – Different mechanisms for complement deposition in arterial and venous thrombosis? Lood, C.
 2011
 48 14 p. 1716-
1 p.
 artikel
164 Pra1 binds and inactivates effector functions of the anaphylatoxin C3a Kupka, D.
 2011
 48 14 p. 1700-
1 p.
 artikel
165 Preeclampsia is associated with defective production of C1q by invasive trophoblast Agostinis, C.
 2011
 48 14 p. 1678-1679
2 p.
 artikel
166 Preface 2011
 48 14 p. 1591-
1 p.
 artikel
167 Preparation of an international complement activation standard. Part one: Optimization of activation conditions Bergseth, G.B.
 2011
 48 14 p. 1706-1707
2 p.
 artikel
168 Preparation of an international complement activation standard. Part two: Storage stability Ludviksen, J.k.l.
 2011
 48 14 p. 1707-
1 p.
 artikel
169 Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia Lynch, A.M.
 2011
 48 14 p. 1718-
1 p.
 artikel
170 Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters Okroj, M.
 2011
 48 14 p. 1716-
1 p.
 artikel
171 Properdin deficiency exacerbates c3 glomerulopathy in factor H knockout mice Lesher, A.M.
 2011
 48 14 p. 1678-
1 p.
 artikel
172 Pseudomonas aeruginosa Lipoamide dehydrogenase (Lpd) binds multiple human plasma proteins for immune escape and to facilitate tissue interaction Hallström, T.
 2011
 48 14 p. 1700-
1 p.
 artikel
173 Purification and biochemical characterization of complement factor H from human plasma fractions Brandstätter, H.
 2011
 48 14 p. 1709-
1 p.
 artikel
174 Purification and characterisation of H-ficolin Zacho, R.M.
 2011
 48 14 p. 1710-
1 p.
 artikel
175 Quantitative analyses reveal substantial differences between Ofatumumab (OFA) and Rituximab (RTX) in mediating Complement-Dependent Cytotoxicity (CDC) of B cell lines and Chronic Lymphocytic Leukemia (CLL) cells Taylor, P.
 2011
 48 14 p. 1711-1712
2 p.
 artikel
176 Quantitative characterization of the autoactivation steps of MASP-1 and -2: Toward a kinetic model of lectin pathway activation Dobó, J.
 2011
 48 14 p. 1668-1669
2 p.
 artikel
177 Reversal of refractory antibody-mediated rejection in blood group incompatible kidney transplantation by Eculizumab Morath, C.
 2011
 48 14 p. 1677-
1 p.
 artikel
178 Risk alleles in complement factor H (CFH) and age-related maculopathy susceptibility 2 (ARMS2) are independently associated with systemic complement activation in age-related macular degeneration (AMD) Smailhodzic, D.
 2011
 48 14 p. 1685-
1 p.
 artikel
179 Role of CRASP-4 in complement resistance of B. burgdorferi Hammerschmidt, C.
 2011
 48 14 p. 1697-
1 p.
 artikel
180 Role of native properdin in the control leptospirosis infection Isaac, L.
 2011
 48 14 p. 1701-1702
2 p.
 artikel
181 Scabies mite complement inhibitors promote growth of Group A Streptococcus Fischer, K.F.
 2011
 48 14 p. 1697-
1 p.
 artikel
182 Sensitive and fast determination of Y402H variants of complement factor H Rutjes-van den Hurk, W.H.
 2011
 48 14 p. 1710-1711
2 p.
 artikel
183 Several genetic aberrations in different complement genes in a patient with dense deposit disease Westra, D.
 2011
 48 14 p. 1682-
1 p.
 artikel
184 Several microbes mimic self surfaces in binding factor H via a conserved site on FH20—A universal target for immune escape? Meri, T.
 2011
 48 14 p. 1698-1699
2 p.
 artikel
185 Shiga-like toxin upregulates production of C3 mRNA and protein in human endothelial cells Volokhina, E.B.
 2011
 48 14 p. 1686-
1 p.
 artikel
186 Silencing of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA enhances complement-dependent cytotoxicity of therapeutic anti-HER2 monoclonal antibodies Mamidi,
 2011
 48 14 p. 1729-
1 p.
 artikel
187 Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice Mihai, S.
 2011
 48 14 p. 1713-
1 p.
 artikel
188 Specificity of anti-histone antibodies determines complement-dependent phagocytosis of necrotic material by polymorphonuclear leukocytes in the presence of serum from patients with SLE. The LE cell phenomenon revisited Gullstrand, B.
 2011
 48 14 p. 1688-
1 p.
 artikel
189 Staphylococcus aureus proteases targeting C3 and chemokine receptors Laarman, A.J.
 2011
 48 14 p. 1702-
1 p.
 artikel
190 Structural and functional characteristics of MBL/Ficolin-associated Protein-1 (MAP-1) Skjoedt, M.O.S.
 2011
 48 14 p. 1668-
1 p.
 artikel
191 Structural basis for complement Factor I control and its disease associated sequence polymorphisms Johnson, S.J.
 2011
 48 14 p. 1668-
1 p.
 artikel
192 Structural features of MBL involved in complement activation Furze, C.M.
 2011
 48 14 p. 1704-1705
2 p.
 artikel
193 Structural insights into the assembly of C4b-binding protein via its oligomerisation domain Lea, S.M.
 2011
 48 14 p. 1675-1676
2 p.
 artikel
194 Structure-Function-Disease map for the genetic abnormalities in the central complement component C3 Roumenina, L.T.
 2011
 48 14 p. 1674-
1 p.
 artikel
195 Synergistic roles for C5aR and C5L2 in the development of anti-GBM nephritis Figge, J.
 2011
 48 14 p. 1690-
1 p.
 artikel
196 Targeted downregulation of mCRPs (CD46, CD55, and CD59) specifically sensitizes transferrin-receptor (CD71) high expressing malignant cells to complement attack Cinci, M.C.
 2011
 48 14 p. 1676-
1 p.
 artikel
197 Targeted-genomic capture and high-throughput sequencing for genetic testing and new gene discovery in atypical hemolytic uremic syndrome Maga, T.K.
 2011
 48 14 p. 1666-
1 p.
 artikel
198 Targeting C/EBPβ sensitises tumours to killing via complement-dependent and complement-independent mechanisms Kolev, V.
 2011
 48 14 p. 1714-
1 p.
 artikel
199 Terminal complement pathway activation and neuroaxonal damage in a mouse model of traumatic brain injury Ramaglia, V.
 2011
 48 14 p. 1730-
1 p.
 artikel
200 The CCP6-8 and CCP19-20 ‘heparin’-binding regions of complement factor H have different and tissue-specific glycosaminoglycan-binding properties Clark, J.
 2011
 48 14 p. 1716-1717
2 p.
 artikel
201 The complement protease MASP-1 triggers proinflammatory reactions in endothelial cells Megyeri, Márton
 2011
 48 14 p. 1689-
1 p.
 artikel
202 The complement regulating properties of gp340 – A new inhibitor of the lectin pathway Reichhardt, M.P.
 2011
 48 14 p. 1705-
1 p.
 artikel
203 The functional properties of Ficolin-A Hummelshøj, T.
 2011
 48 14 p. 1699-
1 p.
 artikel
204 The HNA-4a polymorphism, a variant of CD11b subunit of the CR3, in Brazilian systemic lupus erythematosus patients Toller-Kawahisa, J.E.
 2011
 48 14 p. 1683-
1 p.
 artikel
205 The influence of complement activation on chronic renal inflammation and fibrosis Fearn, A.
 2011
 48 14 p. 1721-
1 p.
 artikel
206 The lectin pathway is inhibited by an anti-coagulant protease inhibitor acting on MASP-2 Wouters, D.
 2011
 48 14 p. 1687-
1 p.
 artikel
207 The MBL-complex is a significant contributor to thrombogenesis in vivo and in vitro La Bonte, L.R.
 2011
 48 14 p. 1731-
1 p.
 artikel
208 The new chimeric alternative complement inhibitor COMP_CFH15–20 protects surfaces from complement-mediated damage Zipfel, F.
 2011
 48 14 p. 1713-
1 p.
 artikel
209 The quantification of serum FHL-1 levels in dense deposit disease and atypical hemolytic uremic syndrome Eyler, S.J.
 2011
 48 14 p. 1708-
1 p.
 artikel
210 The role of complement C6 in regeneration after nerve crush Baas, F.
 2011
 48 14 p. 1725-1726
2 p.
 artikel
211 The role of complement in Streptococcus pneumoniae hand-off to follicular dendritic cells Heesters, B.A.
 2011
 48 14 p. 1672-
1 p.
 artikel
212 The role of functional Mannose-binding lectin deficiency in contrast-induced nephropathy Piezzi, V.
 2011
 48 14 p. 1717-1718
2 p.
 artikel
213 The role of the complement system in nerve damage in leprosy Bahia el Idrissi, N.
 2011
 48 14 p. 1717-
1 p.
 artikel
214 The role of the component C5 in murine models of fatty liver disease: An inflammatory analysis Bavia, L.B.
 2011
 48 14 p. 1692-
1 p.
 artikel
215 The secreted Staphylococcus aureus protein Ecb enhances factor H-C3b contact to down regulate complement activation Amdahl, H.
 2011
 48 14 p. 1673-
1 p.
 artikel
216 The structure of factor H domains 19–20 in complex with C3d explains regulation of alternative pathway amplification on self and pathogen surfaces Bhattacharjee, A.K.
 2011
 48 14 p. 1673-
1 p.
 artikel
217 Thioredoxin-1 and its truncated form, Trx80, have opposing regulatory properties for human complement King, B.C.R.
 2011
 48 14 p. 1707-1708
2 p.
 artikel
218 Three novel C3 mutations in atypical haemolytic uraemic syndrome: Two ways to hyperactive C3 convertase Malina, M.M.
 2011
 48 14 p. 1731-
1 p.
 artikel
219 Treating Dense Deposit Disease by controlling the C3 convertase Zhang,
 2011
 48 14 p. 1715-
1 p.
 artikel
220 Treatment of antigen-induced and collagen-induced arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5 Macor, P.
 2011
 48 14 p. 1676-
1 p.
 artikel
221 Vaccination of a C5-deficient man against Neisseria meningitidis: Effect on opsonophagocytosis and bacterial growth Hellerud, B.C.
 2011
 48 14 p. 1711-
1 p.
 artikel
                             221 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland